flowchart LR
mRNA[secM-secA mRNA] --> Ribosome
Ribosome --> |SecY available| Continue[Translation continues]
Ribosome --> |SecY blocked| Stall[Ribosome stalls]
Stall --> |Structure change| Expose[secA RBS exposed]
Expose --> SecA[SecA synthesis]
Known Stalling Peptides
Validation against characterized prokaryotic ribosome stalling sequences
Overview
Several prokaryotic ribosome stalling peptides have been experimentally characterized. These serve as positive controls for our discovery pipeline.
SecM (Secretion Monitor)
Sequence
FSTPVWISQAQGIRAGP
↑ ↑↑↑
W Stall site
Characteristics
| Property | Value |
|---|---|
| Organism | Escherichia coli |
| Length | 17 residues |
| Stall motif | GIRAGP |
| Function | Secretion regulation |
| PDB | Multiple structures |
Mechanism
SecM stalls ribosomes when the SecY translocon is unavailable, allowing SecA upregulation.
TnaC (Tryptophanase Leader)
Sequence
WDPXXXXIGP (consensus)
↑ ↑↑
W Stall (tryptophan-dependent)
Characteristics
| Property | Value |
|---|---|
| Organism | Escherichia coli |
| Length | Variable (~24 residues) |
| Stall motif | IGP (tryptophan-dependent) |
| Function | Tryptophan catabolism |
| Inducer | L-tryptophan |
Mechanism
TnaC stalling requires free L-tryptophan in the ribosome exit tunnel, linking amino acid availability to gene expression.
MifM (Membrane Insertion Factor Monitor)
Sequence
XXXGPXXGIAGP
↑↑ ↑↑↑↑
GP Stall site
Characteristics
| Property | Value |
|---|---|
| Organism | Bacillus subtilis |
| Length | ~90 residues (full peptide) |
| Stall motif | GIAGP |
| Function | YidC regulation |
| Homologs | Many Firmicutes |
Mechanism
MifM monitors membrane protein insertion via YidC. When insertion is impaired, stalling upregulates YidC2.
CydA (Cytochrome bd Oxidase)
Sequence
XXXRAGP
↑↑↑↑
Stall site
Characteristics
| Property | Value |
|---|---|
| Organism | Escherichia coli |
| Length | Short leader |
| Stall motif | RAGP |
| Function | Cytochrome regulation |
Comparison Table
| Peptide | Motif | Trigger | Response |
|---|---|---|---|
| SecM | GIRAGP | SecY absence | SecA↑ |
| TnaC | IGP | Trp presence | TnaAB↑ |
| MifM | GIAGP | YidC absence | YidC2↑ |
| CydA | RAGP | Unknown | CydB? |
Validation Strategy
Positive Control
Our HMMs should recover known stalling peptides:
- Search prokaryotic databases with seed HMMs
- Check for known peptides in results
- Measure E-values and ranks
Expected Results
| Peptide | Expected E-value | Status |
|---|---|---|
| SecM | <1e-10 | TBD |
| TnaC | <1e-5 | TBD |
| MifM | <1e-8 | TBD |
| CydA | <1e-5 | TBD |
Negative Control
Random GP sequences should not rank highly:
- Shuffle upstream context
- Preserve amino acid composition
- Compare E-value distributions
Novel Discoveries
Criteria for Novel Peptides
- Sequence: Contains xAGP or similar motif
- Context: Inter-domain location
- Conservation: Conserved across species
- Structure: Predicted stalling-compatible
Candidate Validation
Promising candidates should be validated by:
- Ribosome profiling correlation
- Reporter assays (if available)
- Structural modeling
- Phylogenetic analysis
References
- Ito K, Chiba S. (2013) Arrest peptides: cis-acting modulators of translation. Annu Rev Biochem 82:171-202.
- Wilson DN, et al. (2016) Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat Rev Microbiol 14:22-35.
- Seip B, Innis CA. (2016) How Widespread is Metabolite Sensing by Ribosome-Arresting Nascent Peptides? J Mol Biol 428:2217-2227.